Two years after its central role in the Paris Olympics in France, Sanofi is back in its native home once again supporting sport.
Sanofi partnered with the Special Olympics Unified Football World Cup, held from July 6 to 11 in Paris, as an Official Health Partner. This is a tournament for footballers with and without intellectual disabilities and features 300 footballers from more than 20 nations.
As part of its partnership, more than 50 Sanofi employees were involved on-site throughout the week.
“Building on the momentum of Paris 2024, over 2,000 employees across Sanofi have now been trained as volunteers, reflecting a strong culture of engagement around meaningful initiatives,” a Sanofi spokesperson told Fierce Pharma Marketing.
The Big Pharma also created a dedicated “respiratory health space,” which had been developed with French respiratory disease organisation Fondation du Souffle.
Sanofi said that at the end of the week, “more than 300 athletes took part in a personalized health journey, raising awareness and assessing their breathing capacity.”
Sanofi currently markets several respiratory therapies, including co-marketing immunology blockbuster Dupixent, which has a license for certain asthma and COPD patients, as well as its respiratory syncytial virus preventative Beyfortus.
“Paris was hot, but the real heat was on the soccer fields,” said Guillaume Wetzel, Head of Partnerships and Sponsorship, to Fierce.
“The passion, determination and spirit of inclusion we witnessed throughout the Special Olympics Unified Football World Cup made it a truly unforgettable experience. We are very proud to have supported this incredible event as Official Health Partner.”